COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who are receiving or have received a specific type of stem cell transplant (called a T-replete allogeneic hematopoietic cell transplant) for any medical reason, including people who have had a previous transplant
- People whose stem cell donor is either an unrelated donor who is a 9 out of 10 or 10 out of 10 tissue match, or a cord blood donor
- People who are willing and able to attend an in-person follow-up visit at Fred Hutch one year after the transplant, which includes an oral health check
- People who are able to understand and sign a consent form, or who have a legal representative who can do so on their behalf
Who may not be able to join:
- People who have no natural teeth remaining
- People whose transplant uses bone marrow as the source of stem cells
- People whose transplant plan includes certain medications — cyclophosphamide given after the transplant or ruxolitinib — used to help prevent a complication called graft-versus-host disease (GVHD)
- People whose transplant preparation plan includes a medication called anti-thymocyte globulin (ATG)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Armin Rashidi, MD, PhD, Fred Hutch/University of Washington Cancer Consortium
Phone: 206-667-2506
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Probability of moderate-to-severe chronic graft versus host disease
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.